Epidermal Growth Factor Receptor Gene in Non-Small-Cell Lung Cancer: The Importance of Promoter Polymorphism Investigation

about

Epidermal Growth Factor Receptor Gene in Non-Small-Cell Lung Cancer: The Importance of Promoter Polymorphism Investigation

Item

http://www.wikidata.org/entity/Q58567008

description

article

@en

im Oktober 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

Epidermal Growth Factor Recept ...... ter Polymorphism Investigation

@en

Epidermal Growth Factor Recept ...... ter Polymorphism Investigation

@nl

type

Item

label

Epidermal Growth Factor Recept ...... ter Polymorphism Investigation

@en

Epidermal Growth Factor Recept ...... ter Polymorphism Investigation

@nl

prefLabel

Epidermal Growth Factor Recept ...... ter Polymorphism Investigation

@en

Epidermal Growth Factor Recept ...... ter Polymorphism Investigation

@nl

P1476

Epidermal Growth Factor Recept ...... ter Polymorphism Investigation

@en

P2093

Jasmina Obradovic

http://www.w3.org/2001/XMLSchema#string

Nataša Djordjevic

http://www.w3.org/2001/XMLSchema#string

Sonja Pavlović

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals

Genome-wide association study of glioma and meta-analysis

Molecular cloning and characterization of a transcription regulator with homology to GC-binding factor

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer

Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain

First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

EGFR gene copy number as a predictive biomarker for patients receiving tyrosine kinase inhibitor treatment: a systematic review and meta-analysis in non-small-cell lung cancer.

Cancer statistics, 2015

P304

6192187

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2018/6192187

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

2018

http://www.w3.org/2001/XMLSchema#string

P50

Vladimir Jurisic

P5008

ScienceSource

P577

2018-10-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30406002

http://www.w3.org/2001/XMLSchema#string

P921

lung neoplasm

cell surface receptor

cancer research

genetic variation

molecular medicine

non-small-cell lung carcinoma

membrane proteins

lung cancer

Anzim

P932

6204164

http://www.w3.org/2001/XMLSchema#string